SiBreax Competitors and Similar CompaniesClear all

SiBreax's competitors and similar companies include Sinon Therapeutics, ZY Therapeutics, Ligandal and NanoViricides.
SiBreax
SiBreax
SiBreax is a company that develops drugs and hydrogels based on trigger-breakable silicate nano- and microparticles.
Sinon Therapeutics
Sinon Therapeutics
Sinon Therapeutics is a company specializing in neurological diseases.
ZY Therapeutics
ZY Therapeutics
ZY Therapeutics is a company engaged in nanotech drug delivery.
Ligandal
Ligandal
Ligandal is a company creating tailored gene therapies using non-viral, cell-specifically-targeted nanotechnology.
NanoViricides
NanoViricides
NanoViricides is a nano-biopharmaceutical company that develops therapeutics for patients suffering from life-threatening viral infections.
Founding Date
Founding Date
2017
Founding Date
N/A
Founding Date
2015
Founding Date
2013
Founding Date
2005
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Kilchberg, CH HQ
Locations
Durham, US HQ
Locations
HQ
Locations
San Francisco, US HQ
Locations
Shelton, US HQ
Employees
Employees
1
Employees
3
Employees
3
Employees
12
Employees
1743% decrease

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 4.6m
Total funding raised
$ 32.5m
For sources of this data, please see the company profile

View Company Profiles

Sinon Therapeutics
HQ
Durham, US
Employees
3

Sinon Therapeutics is a company specializing in neurological diseases.

View company
ZY Therapeutics
HQ
Employees
3

ZY Therapeutics is a company engaged in nanotech drug delivery.

View company
Ligandal
HQ
San Francisco, US
Employees
12

Ligandal is a company creating tailored gene therapies using non-viral, cell-specifically-targeted nanotechnology.

View company
NanoViricides
HQ
Shelton, US
Employees
17↓ 43% decrease

NanoViricides is a nano-biopharmaceutical company that develops therapeutics for patients suffering from life-threatening viral infections.

View company